Throughout the drug development process, imaging is a fundamental contributor to the generation of primary, secondary, and exploratory study end points. Core labs, central imaging centers and clinical trial sites need to be aware of the risks involved with the use of imaging as reproducible and standardized data. As imaging methods are complex in terms of data acquisition, data transfer and assessments, it is important to identify risks associated with each step. Employing risk management strategies is essential for accurate cost and time management and to ensure overall success of the trial.

Register for this free interactive session to learn:

• What are the risks involved with using imaging in clinical trials?
• How do you identify risks during each phase of the clinical trial process?
• How do you assess the impact these risks will have on trial success?
• How to mitigate common imaging risks to ensure successful outcomes

Bring your issues with mitigating risks when utilizing imaging in clinical trials and we will discuss solutions.